Akari Therapeutics plc ADR (0.01 USD) AKTX
$7.00
-2.51%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-08-13 | View → |
| 10-Q | 10-Q | 2026-08-13 | View → |
| 4 | 4 | 2026-08-05 | View → |
| 4 | 4 | 2026-07-17 | View → |
| 8-K | 8-K | 2026-07-02 | View → |
| S-3 | S-3 | 2026-07-02 | View → |
| 8-K | 8-K | 2026-06-26 | View → |
| 4 | 4 | 2026-06-25 | View → |
| 4 | 4 | 2026-06-25 | View → |
| DEF 14A | DEF 14A | 2026-06-04 | View → |
| 8-K | 8-K | 2026-05-22 | View → |
| 10-Q | 10-Q | 2026-05-19 | View → |
| S-1 | S-1 | 2026-05-08 | View → |
| 10-K | 10-K | 2026-03-30 | View → |
| 8-K | 8-K | 2026-03-17 | View → |
| 4 | 4 | 2026-03-16 | View → |
| 8-K | 8-K | 2026-03-02 | View → |
| DEF 14A | DEF 14A | 2026-02-02 | View → |
| S-1 | S-1 | 2026-01-23 | View → |
| 4 | 4 | 2025-12-18 | View → |
| 4 | 4 | 2025-12-18 | View → |
| 4 | 4 | 2025-12-18 | View → |
| 4 | 4 | 2025-12-18 | View → |
| 4 | 4 | 2025-12-18 | View → |
| 4 | 4 | 2025-12-18 | View → |
| 4 | 4 | 2025-12-18 | View → |
| 8-K | 8-K | 2025-12-17 | View → |
| 424B5 | 424B5 | 2025-12-17 | View → |
| 8-K | 8-K | 2025-12-16 | View → |
| 8-K | 8-K | 2025-12-08 | View → |
| 8-K | 8-K | 2025-11-26 | View → |
| DEF 14A | DEF 14A | 2025-11-17 | View → |
| S-1 | S-1 | 2025-11-17 | View → |
| 10-Q | 10-Q | 2025-11-13 | View → |
| 4 | 4 | 2025-11-04 | View → |
| 4 | 4 | 2025-10-24 | View → |
| 8-K | 8-K | 2025-10-23 | View → |
| 8-K | 8-K | 2025-10-16 | View → |
| 424B5 | 424B5 | 2025-10-16 | View → |
| 8-K | 8-K | 2025-10-15 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $7.00
- Market Cap
- $12.57 million
- 52-Week Range
- $3.02 – $49.60
- Average Volume
- 47K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.